Compare Stitch Fix Inc (SFIX) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stitch Fix Inc vs Zoetis Inc — how do they compare? Stitch Fix Inc trades at $3.56 (market cap $497.68M), while Zoetis Inc trades at $72.48 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 62.6× Stitch Fix Inc's market cap, and Zoetis Inc pays a 2.81% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| SFIX | ZTS | |
|---|---|---|
Market Cap | $497.68M | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $5.83 | $156.76 |
52-Week Low | $3.06 | $71.91 |
Enterprise Value | $385.40M | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stitch Fix (SFIX) trades at $3.565, down 10.2% in the past day, reflecting recent volatility. The stock shows a bullish technical signal with improving earnings trends, as recent quarters beat EPS estimates. Revenue stabilized at $1.27B in 2025, with net losses narrowing to -$28.74M, indicating progress toward profitability. News highlights AI-driven personalization efforts and new executive appointments aimed at growth.
The outlook suggests a turnaround opportunity, supported by a low P/S ratio of 0.37 and a consensus price target of $4.75 (33% upside). Risks include persistent net losses, competitive pressures, and consumer spending sensitivity. Analysts are mixed, with 27% buy ratings, but improving cash flow and debt-free balance sheet provide stability.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
